What is it about?
Neuroinflammation can lead to various degrees of brain damage and behavioural impairment. Here we show that early stage neuroinflammation can be ameliorated using a novel drug that reduces extravasation at the blood-brain barrier.
Featured Image
Read the Original
This page is a summary of: Inhibition of semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 reduces lipopolysaccharide-induced neuroinflammation, British Journal of Pharmacology, June 2017, Wiley,
DOI: 10.1111/bph.13832.
You can read the full text:
Contributors
The following have contributed to this page
